Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14
TSHA Stock | USD 2.52 0.04 1.56% |
About 55% of Taysha Gene's investor base is interested to short. The analysis of the overall investor sentiment regarding Taysha Gene Therapies suggests that many traders are impartial. The current market sentiment, together with Taysha Gene's historical and current headlines, can help investors time the market. In addition, many technical investors use Taysha Gene Therapies stock news signals to limit their universe of possible portfolio assets.
Taysha |
DALLAS, May 07, 2024 -- Taysha Gene Therapies, Inc. , a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system , today announced that it will report its financial results for the first quarter ended March 31, 2024, and host a corporate update conference call and webcast on Tuesday, May 14, 2024, at 430 PM Eastern Time. Conference Call D
Read at finance.yahoo.com
Taysha Gene Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Taysha Gene can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Taysha Gene Fundamental Analysis
We analyze Taysha Gene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Taysha Gene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Taysha Gene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Taysha Gene is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Taysha Gene Therapies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Taysha Gene stock to make a market-neutral strategy. Peer analysis of Taysha Gene could also be used in its relative valuation, which is a method of valuing Taysha Gene by comparing valuation metrics with similar companies.
Peers
Taysha Gene Related Equities
XFOR | X4 Pharmaceuticals | 13.43 | ||||
CCCC | C4 Therapeutics | 9.28 | ||||
CABA | Cabaletta Bio | 6.97 | ||||
BMEA | Biomea Fusion | 6.60 | ||||
STTK | Shattuck Labs | 2.31 | ||||
DAWN | Day One | 0.45 | ||||
INZY | Inozyme Pharma | 0.67 | ||||
AKRO | Akero Therapeutics | 0.95 | ||||
ELYM | Eliem Therapeutics | 1.90 | ||||
STOK | Stoke Therapeutics | 2.11 | ||||
LRMR | Larimar Therapeutics | 2.81 | ||||
TERN | Terns Pharmaceuticals | 3.18 | ||||
GOSS | Gossamer Bio | 4.05 | ||||
ALEC | Alector | 4.07 | ||||
PRLD | Prelude Therapeutics | 5.83 | ||||
HOOK | Hookipa Pharma | 7.88 | ||||
GLUE | Monte Rosa | 9.85 |
Complementary Tools for Taysha Stock analysis
When running Taysha Gene's price analysis, check to measure Taysha Gene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taysha Gene is operating at the current time. Most of Taysha Gene's value examination focuses on studying past and present price action to predict the probability of Taysha Gene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taysha Gene's price. Additionally, you may evaluate how the addition of Taysha Gene to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |